Literature DB >> 16998715

Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy.

S-Q Wang1, Q-S Du, K Zhao, A-X Li, D-Q Wei, K-C Chou.   

Abstract

Recently Simmons et al. reported a new mechanism for SARS virus entry into target cells, where MDL28170 was identified as an efficient inhibitor of CTSL-meditated substrate cleavage with IC(50) of 2.5 nmol/l. Based on the molecule fingerprint searching method, 11 natural molecules were found in the Traditional Chinese Medicines Database (TCMD). Molecular simulation indicates that the MOL376 (a compound derived from a Chinese medicine herb with the therapeutic efficacy on the human body such as relieving cough, removing the phlegm, and relieving asthma) has not only the highest binding energy with the receptor but also the good match in geometric conformation. It was observed through docking studies that the van der Waals interactions made substantial contributions to the affinity, and that the receptor active pocket was too large for MDL21870 but more suitable for MOL736. Accordingly, MOL736 might possibly become a promising lead compound for CTSL inhibition for SARS therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16998715      PMCID: PMC7087620          DOI: 10.1007/s00726-006-0403-1

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  19 in total

1.  Applying high-performance computing in drug discovery and molecular simulation.

Authors:  Tingting Liu; Dong Lu; Hao Zhang; Mingyue Zheng; Huaiyu Yang; Yechun Xu; Cheng Luo; Weiliang Zhu; Kunqian Yu; Hualiang Jiang
Journal:  Natl Sci Rev       Date:  2016-01-11       Impact factor: 17.275

2.  Exploring the ligand-protein networks in traditional chinese medicine: current databases, methods and applications.

Authors:  Mingzhu Zhao; Dongqing Wei
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 3.  Natural product-derived phytochemicals as potential agents against coronaviruses: A review.

Authors:  Janice S Mani; Joel B Johnson; Jason C Steel; Daniel A Broszczak; Paul M Neilsen; Kerry B Walsh; Mani Naiker
Journal:  Virus Res       Date:  2020-04-30       Impact factor: 3.303

Review 4.  In-silico studies in Chinese herbal medicines' research: evaluation of in-silico methodologies and phytochemical data sources, and a review of research to date.

Authors:  D J Barlow; A Buriani; T Ehrman; E Bosisio; I Eberini; P J Hylands
Journal:  J Ethnopharmacol       Date:  2012-02-02       Impact factor: 4.360

Review 5.  Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.

Authors:  Seyed Abdulmajid Ayatollahi; Javad Sharifi-Rad; Patrick Valere Tsouh Fokou; Gail B Mahady; Hafiz Ansar Rasul Suleria; Shivani Krishna Kapuganti; Kundlik Gadhave; Rajanish Giri; Neha Garg; Rohit Sharma; Daniel Ribeiro; Célia F Rodrigues; Željko Reiner; Yasaman Taheri; Natália Cruz-Martins
Journal:  Front Pharmacol       Date:  2021-06-29       Impact factor: 5.810

6.  Exploring the ligand-protein networks in traditional chinese medicine: current databases, methods, and applications.

Authors:  Mingzhu Zhao; Qiang Zhou; Wanghao Ma; Dong-Qing Wei
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-02       Impact factor: 2.629

Review 7.  The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - Additional weapons in the fight against the COVID-19 pandemic?

Authors:  Andréa D Fuzimoto; Ciro Isidoro
Journal:  J Tradit Complement Med       Date:  2020-05-30

Review 8.  Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective.

Authors:  Yang Yang; Md Sahidul Islam; Jin Wang; Yuan Li; Xin Chen
Journal:  Int J Biol Sci       Date:  2020-03-15       Impact factor: 6.580

9.  In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus.

Authors:  Deng-Hai Zhang; Kun-Lun Wu; Xue Zhang; Sheng-Qiong Deng; Bin Peng
Journal:  J Integr Med       Date:  2020-02-20

10.  A rational approach to selective pharmacophore designing: an innovative strategy for specific recognition of Gsk3β.

Authors:  H Pradeep; G K Rajanikant
Journal:  Mol Divers       Date:  2012-08-24       Impact factor: 2.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.